Pharmafile Logo
Pharmafocus logo
Advanced Search

Phase III trial reveals positive results for Crohn’s disease treatment

May 12, 2022
Business Services

AbbVie has announced positive topline results from U-ENDURE, its Phase III maintenance study, evaluating upadacitinib in adult patients with Crohn’s …

News

FDA approve Lilly-Incyte’s treatment for hospitalised COVID patients

May 12, 2022
Business Services

The FDA has granted approval for Eli Lilly and Incyte’s Olumiant (baricitinib) to treat COVID-19 in adult patients admitted to …

News

SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment

May 11, 2022
Research and Development

The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …

News

Europe’s first psychedelic drug trial clinic to open in London

May 11, 2022
Research and Development

British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …

News

Partnership researching genetics and treatments of long COVID

May 11, 2022
Research and Development

PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …

News

Ardena confirms spray drying upgrade and other capabilities at Spanish site

May 11, 2022
Research and Development

 

News

WHO delivers 20 ambulances to Ukraine

May 10, 2022
Manufacturing and Production

In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …

News

MGC Pharma receives patent protection for epilepsy drug

May 10, 2022
Manufacturing and Production

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …

News

Fourth-dose COVID-19 jab demonstrates good boost

May 10, 2022
Manufacturing and Production

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …

News

NIH discovery could advance precise therapies for blinding diseases

May 10, 2022
Manufacturing and Production

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …

News

Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

May 9, 2022
Sales and Marketing

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …

News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022
Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …

News

FDA places partial clinical hold on BioCryst’s lead candidate, BCX9930

May 9, 2022
Sales and Marketing

The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …

News

Case of monkeypox confirmed in England

May 9, 2022
Sales and Marketing

The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …

News
san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Appointment
san

Shabir Hasham

May 6, 2022

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Appointment

Allison Williamson

May 6, 2022

BIOCAPTIVA has announced the appointment of Alison Williamson as Chief Financial Officer, and member of the board.Alison has over 30 …

Appointment
richard_laxer

Richard Laxer

May 6, 2022

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the …

Appointment
karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed …

Appointment
karen_mullen_boyds

Dr Karen Mullen

May 6, 2022

 

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026